Neil Chatterji
Stock Analyst at B. Riley Securities
(0)
# 3000
Out of 3,975 analysts
23
Total ratings
35.71%
Success rate
-2.79%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OptimizeRx | Maintains: Buy | 17 13 | 5.5 | 136.36% | 3 | Dec 24, 2024 | |
Augmedix | Reinstates: Buy | 6 | n/a | n/a | 3 | Apr 3, 2024 | |
Establishment Labs H... | Maintains: Buy | 95 50 | 46.1 | 8.46% | 2 | Nov 9, 2023 | |
Silk Road Medical | Downgrades: Neutral | 54 14 | n/a | n/a | 3 | Oct 11, 2023 | |
Accuray | Reiterates: Buy | 8 | 2.06 | 264.08% | 1 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 18 | 19.21 | -6.3% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | 3.87 | 16.28% | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 1.05 | 233.33% | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 2.36 | 133.05% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 14 | 15.86 | -11.73% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | 10.96 | 191.97% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 4.07 | 133.42% | 1 | Oct 4, 2022 |